Courtney Vinopal is a senior reporter for HR Brew covering total rewards and compliance. Her reporting has appeared in a variety of print, broadcast, and digital outlets, including the Wall Street Journal, Washington Post, PBS NewsHour, and Quartz. Prior to entering journalism, Courtney worked for the press office of the French Embassy in Washington.
The Department of Labor is seeking to increase the minimum wage levels employers must pay to foreign-born workers they’re hiring through visas such as the H-1B program and other labor certifications. Here’s more on what HR needs to know.
CHROs are seeing their pay grow more rapidly than other named executive officers, with median compensation for Russell 3000 CHROs growing by 14.7% between 2024 and 2025, compared to 8.1% for all NEOs. The trend is a reflection of HR’s ever-growing mandate.
DoorDash is one company offering workers emergency relief as gas prices rise due to the US-Israeli war in Iran.
Herbs and spices manufacturer Frontier Co-op has used second-chance hiring practices when considering job applicants since 2018. In the latest edition of our Business of Benefits series, we dig into the design and ROI.
Just 7% of employers offered a phased retirement program in 2025, but those that did have seen a few positive returns. Some see it as a way to give workers additional time to save while transitioning out of roles that are core to their identities. Others say it’s helpful for training the next generation of workers.
Female applicants are more likely to be turned off by jobs with broad pay ranges, but adding context can help.
Nearly all workers in the state would be granted up to 12 weeks of paid leave under the legislation, which Gov. Abigail Spanberger is expected to sign into law.
The unrest has prompted some companies to evacuate their employees, while others have allowed staff to temporarily relocate or work remotely.
While this uptick may seem alarming, there are other factors that might be contributing to it besides a tough economy, Vanguard’s David Stinnett said.
Lilly will offer Zepbound, an injectable GLP-1 medication, at a price of $449 per month through a platform called Lilly Connect.
